We would need to see how the vaccine succeeds (personally, would wish it succeeds). It is in trial stage; to run over the next two years involving up to 30 volunteers. At end of the day it has to be effective, safe, versatile and commercially viable. Will have to wait and see.
As Hiteshbhai says "There is a huge deluge of newsflows on almost all companies and one needs to prioritize what is important and what is not" (for now).
Till then, let's enjoy the joker in the pack (USFDA approval). The single biggest risk factor is behind us. Cheers.